KR20020063180A - 물질 탐닉 치료방법 - Google Patents
물질 탐닉 치료방법 Download PDFInfo
- Publication number
- KR20020063180A KR20020063180A KR1020027005864A KR20027005864A KR20020063180A KR 20020063180 A KR20020063180 A KR 20020063180A KR 1020027005864 A KR1020027005864 A KR 1020027005864A KR 20027005864 A KR20027005864 A KR 20027005864A KR 20020063180 A KR20020063180 A KR 20020063180A
- Authority
- KR
- South Korea
- Prior art keywords
- calcium channel
- amlodipine
- verapamil
- sustained release
- nifedipine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9926218.0 | 1999-11-06 | ||
GBGB9926218.0A GB9926218D0 (en) | 1999-11-06 | 1999-11-06 | Composition and method for the treatment of drug abuse |
GBGB9929595.8A GB9929595D0 (en) | 1999-12-16 | 1999-12-16 | New composition and method for the treatment of drug abuse |
GB9929595.8 | 1999-12-16 | ||
PCT/AU2000/001367 WO2001034161A1 (fr) | 1999-11-06 | 2000-11-06 | Procede de traitement de l'accoutumance aux substances intoxiquantes |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20020063180A true KR20020063180A (ko) | 2002-08-01 |
Family
ID=26316056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027005864A KR20020063180A (ko) | 1999-11-06 | 2000-11-06 | 물질 탐닉 치료방법 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1242093A1 (fr) |
JP (1) | JP2004508274A (fr) |
KR (1) | KR20020063180A (fr) |
CN (1) | CN1402638A (fr) |
AU (1) | AU1256501A (fr) |
CA (1) | CA2390101A1 (fr) |
NO (1) | NO20022157L (fr) |
NZ (1) | NZ518992A (fr) |
WO (1) | WO2001034161A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043345A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
WO2010141712A2 (fr) * | 2009-06-03 | 2010-12-09 | Marquette University | Modulation de l'activité du canal de potassium de kcnq dans le traitement de troubles psychiatriques et de symptômes afférents |
WO2021072213A1 (fr) * | 2019-10-11 | 2021-04-15 | The Trustees Of Indiana University | Prégabaline pour le traitement d'un trouble lié à l'utilisation des opioïdes |
-
2000
- 2000-11-06 JP JP2001536159A patent/JP2004508274A/ja active Pending
- 2000-11-06 KR KR1020027005864A patent/KR20020063180A/ko not_active Application Discontinuation
- 2000-11-06 WO PCT/AU2000/001367 patent/WO2001034161A1/fr active IP Right Grant
- 2000-11-06 AU AU12565/01A patent/AU1256501A/en not_active Abandoned
- 2000-11-06 CN CN00816640A patent/CN1402638A/zh active Pending
- 2000-11-06 NZ NZ518992A patent/NZ518992A/en unknown
- 2000-11-06 EP EP00974161A patent/EP1242093A1/fr not_active Withdrawn
- 2000-11-06 CA CA002390101A patent/CA2390101A1/fr not_active Abandoned
-
2002
- 2002-05-06 NO NO20022157A patent/NO20022157L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1256501A (en) | 2001-06-06 |
EP1242093A1 (fr) | 2002-09-25 |
CN1402638A (zh) | 2003-03-12 |
NO20022157L (no) | 2002-07-04 |
JP2004508274A (ja) | 2004-03-18 |
WO2001034161A1 (fr) | 2001-05-17 |
NZ518992A (en) | 2004-02-27 |
CA2390101A1 (fr) | 2001-05-17 |
NO20022157D0 (no) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8426439B2 (en) | Compositions and methods for prophylaxis and treatment of addictions | |
US6071918A (en) | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence | |
US20040024006A1 (en) | Opioid pharmaceutical compositions | |
WO2001052851A1 (fr) | Methodes de traitement d'abus de substances | |
WO2000021515A9 (fr) | Codeine intra-nasale permettant d'eliminer rapidement la toux et de soulager rapidement la douleur | |
KR101767273B1 (ko) | 중독의 예방 및 치료용 조성물 및 방법 | |
KR20020081271A (ko) | 물질 남용의 치료 방법 | |
AU2002323873B2 (en) | Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism | |
JPS6342605B2 (fr) | ||
MXPA02003670A (es) | Sales y bases de 17-(ciclopropilmetil)-4,5 alfa-epoxi-6-metilenomorfinan-3,14 diol para optimizar la homeostasis de dopamina durante la administracion de analgesicos. | |
JP7244992B2 (ja) | オピオイドとn-アシルエタノールアミンの組み合わせ | |
KR20090125748A (ko) | 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법 | |
KR20020063180A (ko) | 물질 탐닉 치료방법 | |
WO2011109743A2 (fr) | Effets synergiques d'associations de buprenorphine et d'opioïdes pour le traitement des douleurs | |
CN111479592A (zh) | 阿片样物质使用障碍、阿片样物质戒断症状和慢性疼痛的治疗 | |
US20190022077A1 (en) | Compositions and methods for prophylaxis and treatment of addictions | |
AU2001226574A1 (en) | Methods for the treatment of substance abuse | |
EP1250136A1 (fr) | Methodes de traitement d'abus de substances | |
JP2009510158A (ja) | 毒物依存症の治療におけるネボグラミンの使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |